![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HIV Replication, Inflammation, and the Effect of Starting Antiretroviral Therapy on Plasma Asymmetric Dimethylarginine (ADMA), A Novel Marker of Endothelial Dysfunction (HAART Improves Endothelial Dysfunction Marker ADMA which in the general pop is associated with CVD & mortality)
|
|
|
Reported by Jules Levin
CROI 2012 March 5-8 Seattle WA
1,2 Jason V. Baker, 1Jacqueline Neuhaus, 1Daniel Duprez, 3Matthew Freiberg, 4Jose I. Bernardino, 5Andrew D. Badley, 6Daniel E. Nixon, 7Jens D. Lundgren, 8Russell P. Tracy and 1James D. Neaton for the INSIGHT SMART Study Group
1University of Minnesota, Minneapolis, MN, USA; 2Hennepin County Medical Center, Minneapolis, MN, USA; 3University of Pittsburgh, Pittsburgh, PA, USA; 4Hospital La Paz, IdiPAZ, Madrid, Spain; 5Mayo Clinic, Rochester, MN, USA;
6Virginia Commonwealth University, Richmond, Virginia, USA; 7University of Copenhagen & Copenhagen University Hospital, Copenhagen, Denmark; 8University of Vermont, Burlington, VT, USA
![CROI1.gif](../images/032612/032612-15/CROI1.gif)
![CROI2.gif](../images/032612/032612-15/CROI2.gif)
![CROI3.gif](../images/032612/032612-15/CROI3.gif)
![CROI4.gif](../images/032612/032612-15/CROI4.gif)
![CROI5.gif](../images/032612/032612-15/CROI5.gif)
![CROI6.gif](../images/032612/032612-15/CROI6.gif)
![CROI7.gif](../images/032612/032612-15/CROI7.gif)
![CROI8.gif](../images/032612/032612-15/CROI8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|